This lecture discusses how seemingly innocuous injuries in very young children are strongly correlated with more serious occult injuries from abuse, and/or precede escalating and potentially fatal abuse in the future. The lecture will also discuss how medical providers can use a validated decision-making tool when assessing injuries in these young children. In addition it will address how providers can acknowledge their explicit and implicit biases and work to prevent these from affecting their decision to act in these difficult situations.

This lecture will provide an evidence based approach to acute and chronic rhinosinusitis that also considers the nonmedical factors that influence health outcomes in order to reduce the economic impact on our patients and healthcare system.  Objectives include: 

1. Discuss the difference between viral rhinosinusitis, acute bacterial rhinosinusitis and chronic rhinosinusitis.
2. Describe an evidence approach for the use of medications in treatment of viral rhinosinusitis, acute bacterial rhinosinusitis and chronic rhinosinusitis.
3. Recognize the non-medical factors (SDOH) associated with viral rhinosinusitis, acute bacterial rhinosinusitis and chronic rhinosinusitis that may influence patient outcomes.

Sleep is as important for good health as diet and exercise. Quality sleep improves brain performance, mood, and health. Not getting enough quality sleep regularly raises the risk of many diseases and disorders ranging from heart disease and stroke to obesity and dementia. Adults ages 18 and 64 need seven or more hours of per night. Adults ages 65 or older need seven to eight hours. More than one-third of U.S. adults average less than seven hours of sleep per night. PAs and NPs are often the first line in recognizing and treating sleep disorders through medications and lifestyle interventions. Objectives include:

1. Discuss the need for sleep.
2. Identify socioeconomic impacts on sleep.
3. Describe methods for evaluation of sleep.
4. Compare and contrast sleep medications.
5. Discuss lifestyle interventions to improve sleep. 

With the introduction of new CKD staging (without the race modifier), KDIGO has released all new guidelines! New HTN goals, new testing and management of albuminuria, new diabetes guidelines, and new CKD medications. One in 3 of your patients is at risk for CKD; do you know who they are?  Come to Kidney Disease Update for 2024 to learn how to identify and manage CKD for the 21st century!  Objectives include: 

1. Define stages of CKD highlighting the removal of race in the eGFR calculator.
2. Review urinary testing needed to both stage and predict progression of CKD.
3. Discuss new KDIGO guidelines for management of CKD patients with a goal to slow disease progression.

Diabetes mellitus (DM), cardiovascular disease (CVD), and chronic kidney disease (CKD), collectively referred to as cardio-renal-metabolic diseases, are associated conditions with intertwined clinical outcomes. Despite advances in management of patients with cardio-renal-metabolic conditions, significant knowledge and care gaps exist. Primary care practitioners (PCPs) are uniquely positioned to diagnose and treat these conditions and can be instrumental in reducing cardiometabolic risk.  Objectives include: 

1. Identify CKD in patients with reduced kidney function, including in early stages of disease. 
2. Describe the link between DM and CVD, including the impact on health outcomes.
3. Select appropriate treatment for patients with DM, CVD, and/or CKD/DKD based practice guidelines and clinical evidence. 
4. Recognize the importance of multidisciplinary care when managing patients with cardio-renal-metabolic conditions.

This lecture will provide a survey of infectious diseases that are emerging (or reemerging) in the US. Objectives include:

1. Describe multiple infectious diseases that have newly emerged in the US or reemerged as threats to the public.
2. Identify the following as emerging or reemerging diseases in the US.
3. Address the diagnosis and treatment of these new and reemerging diseases.
4. Discuss the role of social determinants of health such as poverty, suboptimal housing, poor sanitation, and differences in rates of vaccination on the prevalence of new and reemerging infectious diseases.

Anemia is encountered in all areas of medicine. It is important to know how to identify anemia and how to best approach it in the specific field of medicine you are practicing. This lecture aims to provide an overview of anemia and how to approach it from a general practitioner's standpoint. This is done through real life case studies to engage the viewer and apply the textbook information into clinical practice. It also aims to help providers identify when a formal hematology evaluation is needed.  Objectives include:

1. Discuss how to identify anemia

2. Discuss the various causes of anemia

3. Discuss typical laboratory and clinical findings

4. Identify various treatment options for anemia for patients with various social determinants of health. 

5. Identify when to refer to Hematology

This presentation is designed to provide an overview of psoriatic arthritis and its place in the hierarchy of rheumatic disease along with the current ACR diagnostic criteria.  The goals of this presentation are to provide participants with the essential information required to develop a differential diagnosis as well as a better understand of the current guidelines for and pitfalls in care for patients with psoriatic arthritis.  Objectives include: 

1. Compare the common features of psoriatic arthritis with other types of seronegative spondyloarthropathies.

2. Describe the factors underlying the pathogenesis of psoriatic arthritis using the ACR diagnostic guidelines.

3. Recognize early signs and symptoms of psoriatic arthritis versus other types of inflammatory joint disease.

4. Develop a strategy to manage patients with psoriasis and psoriatic arthritis and disease comorbidities.

5. Define the course and prognosis of psoriatic arthritis.

Effective and timely ways to address, screen, treat and code for substance use disorder in primary care medicine.  You will hear about how my family was personally affected by substance use disorder (SUD). Objectives include:

1. Recognize health disparities when treating substance use disorder. 
2. Illustrate effective ways to talk to your patients and patient's families about substance use disorder.
3. Apply the current and readily available screening tools in your practice.
4. Demonstrate how to appropriately treat patients with SUD beyond the need for a DEA(x) number and applying the appropriate ICD-10 codes.
5. Identify ways to reduce SUD stigma in patient assessment and care. 

This lecture will focus on medical coding.  Objectives include:   

1. Understand the impact of medical coding on your healthcare system.

2. Know the difference between an acute, uncomplicated illness from an acute illness with systemic symptoms.

3. Define the criteria needed for a level 3 and a level 4 office visit.

4. Recognize the importance of documentation when choosing the correct level of service.

5. Define Social Determinants of Health and how it factors into the risk of patient management.